Pharmaceutical Barium sulfate
How to stay on the moon after we get there
Our civilization is built on structural steel. This is the most necessary metal in history. It is not…
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Advances Mine-to-Bottle Strategy for Critical Mineral Barium and Iodine Contrast Products
June 26, 2025 — Prices for pharmaceutical-grade barium sulfate “are up over 40-50% in just a few months,”…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Wednesday, June 25, 2025 at 9 AM EST
InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, June 25th, at 9 AM EST, featuring Brent Willis, President, CEO,…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, February 6, 2025
Investor.News is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, February 6th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Brent Willis on Voyageur’s ambition to revolutionize radiology by vertically integrating the barium and iodine contrast market
June 3, 2024 — InvestorNews host Pat Bolland interviews Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
3 CommentsInvestorNews
InvestorNews Member News
-
Ucore Rare Metals and Sumitomo Corporation of Americas Announce Strategic Collaboration in Rare Earth Supply Chain
-
First Phosphate Closes Oversubscribed Private Placement to Existing and Follow-on Investors
-
Nord Precious Metals to Present at the June 16, 2026 Energy & Precious Metals Virtual Investor Summit
-
Volta’s Drill Hole SL25-25 Returned 0.40% TREO and 44.5 g/t Ga2O3 over 417.8 m Including 174.7 g/t Gallium Oxide, 3.73% TREO and 5,146 g/t Neodymium Oxide over 2.2 m
-
PEA for Resouro’s Tiros Project outlines strong economics with after-tax NPV(8%) of US$714.9 M and IRR of 44.2%
